pancreatic cancer
Showing NaN - NaN of 77
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)
Completed
- Pancreatic Cancer
- +2 more
- AMG820 and pembrolizumab
-
Atlanta, Georgia
- +14 more
Jan 18, 2023
Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)
Active, not recruiting
- Pancreatic Cancer
- +2 more
-
Sacramento, California
- +31 more
Jan 12, 2023
Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)
Active, not recruiting
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 9, 2023
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Pancreatic Cancer, Cancer of the Pancreas Trial in Philadelphia (huCART-meso cells)
Recruiting
- Pancreatic Cancer
- Cancer of the Pancreas
- huCART-meso cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 9, 2022
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022
Pancreatic Cancer Trial in Philadelphia (PLDR)
Recruiting
- Pancreatic Cancer
- PLDR
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 18, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
-
Tampa, Florida
- +7 more
Jul 13, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Pancreatic Cancer in Patients With Inherited Genetic Risk
Recruiting
- Pancreatic Cancer
- surveillance endoscopic ultrasound or MRI of the abdomen
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 1, 2022
Pancreatic Cancer Trial in Philadelphia (Nivolumab, Nab-Paclitaxel, Gemcitabine)
Terminated
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 19, 2022
Pancreatic Cancer Trial in Philadelphia (Paricalcitol)
Terminated
- Pancreatic Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 29, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)
Recruiting
- Pancreatic Cancer
- Serous Ovarian Cancer
- VCN-01
- huCART-meso Cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 17, 2022
Pancreatic Cancer Trial in United States (Directional Brachytherapy Source Implant)
Recruiting
- Pancreatic Cancer
- Directional Brachytherapy Source Implant
-
Chicago, Illinois
- +4 more
Mar 1, 2022
Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)
Active, not recruiting
- Pancreatic Cancer
- mFOLFIRINOX
- +2 more
-
Scottsdale, Arizona
- +7 more
Feb 14, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022